Botanical guide · Ingredient reference

Chinese skullcap: limited trials, liver reports and drug interactions

Distinguish Scutellaria baicalensis, isolated constituents and multi-herb formulations.

Read the evidence ↓

Supplement Science Insights Editorial Team

Published September 23, 2026

What the research addresses

Chinese skullcap, Scutellaria baicalensis, is used in traditional formulas and contains compounds such as baicalin. MSK describes limited human research. Findings for a formula or isolated constituent do not establish equivalent benefits from the herb alone. [1]

What the finding does not establish

Laboratory anticancer or anti-inflammatory effects are not clinical treatment results. A small study alongside another therapy also needs to be interpreted within that combination rather than as proof of an independent supplement effect. [1]

Preserve both uncertainty and the safety signal

Suppose liver injury occurs after a multi-ingredient product. The report may not identify which ingredient caused it, but that uncertainty does not make the product harmless. Record the full formulation and event instead of either blaming one ingredient with certainty or dismissing the report.

Apply the same standard to favorable findings. If the study used a blend, avoid assigning the improvement to skullcap alone. Consistent treatment of positive and negative evidence produces a more useful assessment than switching standards depending on whether a result supports a sale.

Hypothetical example — illustrates evidence interpretation; not a product or dose recommendation.
Hypothetical finding or choiceWhat it means
A blend is linked to liver injuryA safety signal with attribution uncertainty
A blend improves a symptomCannot isolate skullcap's contribution
An isolated constituent changes drug levelsRelevant to a medication review

Safety and treatment considerations

Liver injury has been reported with skullcap-containing formulas, and pneumonitis is described in the source. Baicalin reduced statin blood levels in a volunteer study. Other potential interactions, including with blood thinners, have uncertain clinical importance. Discuss use before combining it with medicines. [1]

A practical next step

No Chinese-skullcap product or dose is recommended. Bring the full label and medicine list into any discussion, and do not assume another plant sold under the common name skullcap has the same evidence or risks.

Chinese skullcap: limited trials, liver reports and drug interactions — original article outline diagram
Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

Sources for this article

  1. Memorial Sloan Kettering Cancer Center — Scutellaria baicalensis
    Source consulted: 2026-09-17. This is a reference resource, not a claim that we conducted the studies or tested a product.